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Objective: We proposed to investigate the areas in psychooncological 
counseling that patients reported as causing the most distress, as well as the level of 
emotional distress cancer inflicts and it's relation to idiosyncratic variables. Method: A 
sample of fifty-one patients from Porto's IPO responded to a socio-demographic and 
clinical questionnaire, to the CORE-10, to the Distress Thermometer, and to an 
idiographic measure, the Simplified Personal Questionnaire (PQ). The therapists 
completed a questionnaire regarding their adherence to the PQ protocol. The data 
analysis consisted of assessing the patients emotional distress and thematically 
analyze the PQ. Results: The patients showed a high level of emotional distress 
regarding the problems described in the PQ. The main areas of issues patients indicate 
were Life Functioning, Anxiety and Depression. Conclusions: The psychosocial 
implications of the disease in the day-to-day functioning was the main area identified as 
a priority for counseling, which attests to the importance of focusing initial oncological 
counseling on helping patients overcome their limitations. 
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Áreas de aconselhamento psicooncológico reportadas por pacientes 
 
Objetivo: Propusemo-nos investigar as áreas de aconselhamento 
psicooncológico que os pacientes reportam como causadoras de maior sofrimento, 
bem como o nível de sofrimento emocional causado pelo cancro e a sua relação com 
variáveis idiossincráticas. Método: Uma amostra de cinquenta e um pacientes do IPO 
do Porto responderam a um questionário sociodemográfico e clínico, ao CORE-10, ao 
Termómetro de Sofrimento Emocional, e a uma medida ideográfica, o Simplified 
Personal Questionnaire (PQ). As terapeutas completaram um questionário de adesão 
ao protocolo do PQ. A análise dos dados consistiu na avaliação do sofrimento 
emocional dos pacientes e na análise temática do PQ. Resultados: Os pacientes 
apresentaram um alto nível de sofrimento emocional relativamente aos problemas 
descritos no PQ. As principais áreas de apoio indicadas pelos pacientes foram 
Funcionamento Vital, Ansiedade e Depressão. Conclusões: As implicações 
psicossociais da doença no dia-a-dia foi a principal área identificada como uma 
prioridade para o aconselhamento, o que atesta a importância de focar o 
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The impact of cancer is global and it not only takes a physical toll, it brings with 
it many psychosocial implications. This has been the focus of many studies before, 
however, the majority of these studies and analysis of the oncological population are 
made from the view point of health professionals and academics not taking into 
account the views of the patients themselves. This gap is precisely what this study 
proposes to fill by giving the patients who indeed suffer the implications of an 
oncological disease the chance to be heard and report the areas they feel should be 
addressed in psychooncolgical counseling. With this in mind we propose to define a 
baseline for psychooncological counseling, to assess the patients need for counseling, 
and to create patient profiles regarding their clinical and social-demographic 
characteristics. In order to achieve our propositions the study was conducted in a 
naturalistic manner in a psychooncological counseling unit where the patients 
psychological distress was analyzed and their counseling priorities were reported. In 
order to facilitate the analysis of the patients point of view we decided on an idiographic 
measure over regular interviews. The measure chosen was the Simplified Personal 
Questionnaire (PQ) (Elliott, Mack & Shapiro, 1999), which was also analyzed in 
regards to the feasibility of its regular usage in a psychooncological counseling context. 
This study was organized according to the Strobe Statement for Cross 
Sectional Studies (von Elm et al., 2008). Beginning with a theoretical framework that 
portrays the condition affecting the patients and the various possibilities of treatment. 
Followed by the psychosocial implications of the disease and the psychological impact 
of distress in cancer patients. The relevance of psychological counseling for 
oncological patients is then addressed as well as a description of the various formats it 
can take. The theoretical framework comes to a close on the explanation of the 
purpose of the study and its importance as well as a clear definition of the objectives. 
The description of the study follows the theoretical framework, starting with the 
participants - two psychologists and fifty one patients - and the five instruments used - 
10-item Clinical Outcomes in Routine Evaluation questionnaire; Simplified Personal 
Questionnaire; Distress Thermometer; Socio-demographic and Clinical Questionnaire; 
Therapist's Adherence to Protocol Questionnaire. Then the data's collection and 
analysis are explored. The analysis begins with the examination of the quality of the 
PQ items and the therapists adherence to the PQ protocol. Then the analysis focuses 
on the emotional state of the patients and afterward on the portrayal of the patients' 
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problems and priorities. The last stage of the analysis scrutinizes the relationship 
between the patients' emotional distress and, personal and disease related variables. 
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1. Introduction to Cancer  
1.1. Definition 
Cancer is a generic term that represents a group of diseases whose main 
feature is the accelerated and uncontrolled growth and spread of cells that can affect 
any part of the body as well as invade the adjacent tissue and metastasize to distant 
locations. The process of metastasis is one of the prime causes of death from cancer 
(WHO, 2014). 
Since the beginning of the 20th century cancer's incidence and mortality rates 
have been steadily increasing, making it one of the most severe threats to a healthy 
life. The number of people who were diagnosed with cancer and died of the disease 
reached 10.1 million and 6.2 million respectively in 2000 (Dong et al., 2002) and these 
figures increased to 10.86 and 6.73 million only two years later (Stewart et al., 2003). It 
is estimated that, by 2020, people living with cancer will add up to 30 million and 
annual new cases and deaths of the disease will rise to 15 million and 10 million 
(Parkin et al., 2005). Despite the steadily increasing mortality rates, the figures 
regarding survival have also improved. Since 1971's until 2011 the 5 year survival rate 
for all types of cancer in England and Whales grew on average 24.5% while the 1 year 
survival rate grew 20.4% and the 10 year survival rate grew 25.8%. When specifying 
the type of cancer some growths of the survival rates are staggering, for example the 
multiple myeloma survival rate more than tripled from 12.6% to 44.5% while for 
leukemia an low 11% survival rate grew to 55.6% (Quaresma, Coleman, & Rachet, 
2015).  
1.2. Development Stages  
There are various stages of oncological disease that describe the extent or 
spread of cancer cells at the time of diagnosis, the most commonly used staging 
system refers to four stages (WHO, 2014): 
- Stage 0 - in this stage cancers are still located in the place they started and 
have not invaded nearby tissues. This stage of cancer is often highly curable, usually 
by removing the entire tumor with surgery. 
- Stage I - This is usually a small cancer or tumor that has not grown deeply into 
nearby tissues and has not spread to the lymph nodes or other parts of the body. It is 
often called early-stage cancer.  
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Stage II and III - These stages indicate cancers or tumors that are larger in size, 
have grown more deeply into nearby tissue, and have spread to lymph nodes, but not 
to other parts of the body  
- Stage IV - This stage means that the cancer has spread to other organs or 
parts of the body. It may also be called advanced or metastatic cancer. 
1.3. Treatment 
The type of cancer treatment depends on the type, location, and stage of the 
cancer as well as the general health status of the patient. For any type of treatment 
patient consent is always required. The most common cancer treatments available are 
surgery, chemotherapy, and radiation therapy, but there are other types of treatment 
that can help patients battle the disease, such as hormone therapy - occasionally used 
to treat certain kinds of prostate and breast cancers - immunotherapy - intended to 
boost the cancer patient’s own immune system to help fight the cancer - targeted 
therapy - targets the cancer cells and causes less damage to healthy cells - and stem 
cell or bone marrow transplants (Skeel & Khleif, 2011).  
Cancer surgery may be the best chance of a treatment for many types of 
cancer, removing all of the cancerous cells as soon as possible after the diagnosis. 
Curative surgery, as it is called, is done when the cancer is found in only one part of 
the body, and the likelihood of total removal is high. Meaning that usually when the 
cancer is in Stage 0 or I the surgery will be most likely possible whereas in Stages II 
and III it may be more difficult to be ensure that the removal of the cancer will be 
complete, and in Stage IV surgery is no longer an option. This type of treatment can be 
used by itself or in league with other treatments such as chemotherapy or radiation 
therapy, which can be given before or after the operation to shrink the cancerous cells 
and facilitate their removal or to eliminate the ones that could not be removed during 
the surgery (Rosenberg, 2011).  
Radiation Therapy helps destroy the cancer cells by damaging the DNA within 
said cells, the normal cells may also be affect but have a higher ability to resist the 
radiation. This type of treatment is achieved, mainly, through irradiation where high-
energy waves (x-rays, gamma-rays, electron beams, protons) are externally directed at 
the cancer cells but there is also the possibility of internal radiotherapy where a 
radioactive foreign object is placed inside the body near the tumor (Chao, Perez, & 
Brady, 2011). 
Chemotherapy is a form of cancer treatment that uses chemical substances to 
treat the disease killing cells that rapidly divide, as cancer cells do. Chemo can be 
effective throughout the whole body whereas surgery, as well as radiation, can only 
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affect cancer cells in a determined area of the body. Hence, chemotherapy is the most 
effective type of treatment for Stage IV cancers because the cancer cells are 
metastasized to various parts of the body (Skeel & Khleif, 2011). There are well over 
100 chemical substances that can be used for chemotherapy treatments. Alone chemo 
drug can be used to treat cancer, but it is more common that multiple drugs are 
selected to administer in a certain order or combination (combination chemotherapy) to 
have a better and faster effect. The usage of various types of chemotherapy drugs with 
diverse actions can work also reduce the chance of the cancer becoming resistant to 
any specific drug (in idem). 
All these types of treatments are, of course, very violent for the whole body, not 
just the cancerous cells, and there are always side effects that surface after the patient 
is subjected them. The side effects of cancer surgery are no different than any other 
surgery, meaning that pain, small infections, bleeding, and a slower recovery of regular 
bodily functions are to be expected (Rosenberg, 2011). Commonly people who are 
subjected to radiotherapy present a variety of skin problems as the main side effect, 
such as itching, peeling, dryness, or blistering, but they also generally feel a persistent 
sense of exhaustion that does not improve after a long rest or with a decrease of 
physical activity (Chao, Perez, & Brady, 2011). In regards to chemotherapy, this being 
the most invasive type of treatment, the side effects are greater in number and severity, 
but may vary depending on the type of chemicals used, fatigue, like in radiotherapy, is 
a main side effect. Pain, general or specific such as muscular pain, stomach pain, or 
headaches is also a very common side effect of this type of treatment. Beyond these 
the patients also tend to experience nausea and vomiting, diarrhea/constipation, mouth 
and throat sores, appetite loss, hair loss, cognitive dysfunction, sexual and 
reproductive issues, or even blood disorders (Skeel & Khleif, 2011). However, not all 
side effects are as physical as these, there is always a psychological and cognitive 
aftermath to these treatments which will be explored in detail further on.  
Another characteristic of cancer is the possibility of recurrence. Cancer may 
recur in four different ways: local recurrence - occurs in the same area -, regional 
recurrence - occurs in the lymph nodes near the previously treated area -, and distant 
recurrence - occurs at a remote location and is considered a metastasis of the original 
cancer. Cancer recurrence can occur due to several factors, many may be the 
variables that determine the probability of reoccurrence but the more prominent are 
tumor size, lymph node status, and type of cancer (Ricks, 2005). 
After the detailed description of cancer and its impact, a broad description of 
cancers' development and its treatments becomes apparent, recognizing five 
distinctive phases: diagnosis - first confrontation with the disease -, advanced disease - 
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cancer stages 3 and 4 -, treatment - battling the disease in various ways -, survival - in 
complete remission for over five years after the treatment, and recurrence - the 
resurfacing of a previously battled cancer (Hewitt, Greenfield, & Stovall, 2006). 
This is the affliction that ails our subjects, viewed from a medical standpoint, 
which not only carries many psychological and social implications but is also influenced 
by those same factors.  
 
2. The Psychosocial Implications of Cancer 
Associated with the great physical damages it causes, cancer inflicts an 
enormous psychological and social distress. Although the prevalence of psychological 
distress is dependent on the type of cancer, time since diagnosis, prognosis, and other 
variables, it can be estimated that 29 to 43 percent of cancer patients suffer from it 
significantly (Carlsen et al., 2005; Hegel et al., 2006; Mitchell et al., 2011;Spiegel & 
Giese-Davis, 2003; Zabora et al., 2001). Generally, cancer patients find themselves in 
an extreme fragile state after the diagnosis, for it represents an unexpected crisis in the 
patients' life cycle and may also bring about changes in the family's structure 
(Kornblith, 1998). Seeing as a cancer diagnosis is usually associated with a great 
amount of distress from a firsthand confrontation with death, a prospect of great pain 
and anguish possibly joined by a disbelief in remission, joined by feelings of guilt, a 
sense of loss of control, confusion, anger and sadness, also body image related 
concerns and family cohesion problems may emerge (Charmaz, 2000; Gregurek et al., 
2010; Jacobsen et al., 2000; Kornblith, 1998; Stanton et al., 2001), all of which can be 
worked on in counseling. There is a type of distress adjacent to any confrontation with 
death, and a cancer diagnosis is no different, which is a confrontation with the patients' 
faith and spirituality as well as an adjustment of their perceived relationship with their 
deity (IOM & NRC, 2006). This distress is prolonged because it is present throughout 
the various stages of the disease and sometimes (approximately 30% of cancer 
patients) culminates in the development of psychopathology, namely anxiety and 
adjustment disorders and most commonly depression, meaning that the patients in fact 
needs mental care (Akechi et al., 2001; Grassi et al., 2004; Kissane et al., 2004; 
Mitchell et al., 2011; Miovic & Block, 2007; Mystakidou et al., 2005). Although these are 
the psychological disorders that surface the most there is another which is of some 
import - Post-Traumatic Stress Disorder (PTSD). From what has been reported above 
and according to the DSM5 a cancer diagnosis qualifies as a traumatic event (APA, 
2013), and there have been reports of PTSD symptoms not only in the cancer patients 
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themselves but also in close family members who go through the traumatic experience 
with them (Bruce, 2006; Kangas et al., 2002).  
Various studies indicate a high correlation between symptoms of depression 
and anxiety and elevated mortality for almost all cancers (Jefford et al., 2008; Kye et 
al., 2012; Pandey et al., 2006; Song, 2011; Su et al., 2004; Yu et al., 2006). These 
psychological effects are also relevant because they are intimately related to the 
cancer's development, progression, or resurgence (Lutgendorf et. al, 2005; Moreno-
Smith, et. al, 2010), which means that addressing these issues as early as possible 
only betters the patients prospects of overcoming the disease.  
The Institute of Medicine of the National Academies (IOM) and the American 
National Research Council (NRC) have found that a cancer patient is also prone to 
experience some inability to make plans due to a fear of the future, particularly a fear of 
recurrence and they can also suffer changes in their sexual function and/or 
reproductive ability which can then pertain to other distressful preoccupations. This fear 
of cancer recurrence has been proven to be one of the most common problems to be 
reported by cancer patients and is considered a multidimensional construct that can 
vary from a normal and expected reaction to a clinically significant one (Baker et. al, 
2005; Thews et. al, 2012). In a systematic review of 68 quantitative studies that 
evaluated the fear of cancer recurrence, it was found that, on average, 73 percent of 
cancer survivors reported a fear of recurrence to some degree, 49 percent reported a 
moderate to high degree of fear of recurrence, and 7 percent reported a high degree of 
fear (Simard et. al, 2013). 
 
3. Psychological Impact of Distress in Cancer Patients  
In recent years researchers have begun to develop a profound understanding of 
the complex relationship between psychological distress and cancer progression. 
There are links between psychological factors and the onset of cancer, but these links 
seem to be more significant when the psychological factors are associated with cancer 
progression (Lutgendorf et. al, 2010; Ross, 2008). Negative psychological aspects 
such as depression and hopelessness may have a direct impact on disease 
progression and survival probability (Steel et al, 2007; Watson et. al, 1999) augmenting 
the former and reducing the latter. Chronic stressors and anxiety can be considered an 
important risk factor not only for cancer occurrence but also for growth and metastasis 
(Chida et al, 2008; Garsen, 2004; Sood et. al, 2006; Thaker et. al, 2006). 
Although the way these psychological factors affect patients always differs 
depending on the idiosyncrasies of the patient's condition including prognosis, 
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treatment type and pain, which are mainly determined by the cancer's characteristics 
namely type and stage (Ciaramella & Poli, 2001), there is a bio-neurological 
explanation for the impact of distress on cancer progression (Yuan, Wang, Li, & Huang, 
2010) (see Fig.1).  
 
Fig. 1 The bio-neurological model for the impact of distress on cancer 
progression (Yuan, Wang, Li, & Huang, 2010) 
 
According to this model, alterations to stress-related neuroendocrine 
transmitters when under psychological distress can lead to a modulation of the chief 
mechanism against tumor cells, immune cells responses. The impact of distress on the 
immune response is mediated by a complex signal network between the immune, 
endocrine, and nervous systems, and the chronic stressors are associated with a 
suppression of immune functions (Reiche, Nunes, & Morimoto, 2004). For instance, 
stress hormones affect the immune function through receptors present on immune 
cells, and the immune cells in turn modulate the activity of the hypothalamus by 
producing cytokines (small proteins that are important in cell signaling and function 
regulation). Glucocorticoid receptors (GRs) expressed on a variety of immune cells, 
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which bind cortisol, interfere with the function of nuclear factor-κB (NF-κB), which 
regulates the activity of cytokine-producing immune cells. Adrenergic receptors (ARs) 
bind epinephrine (EPI) and norepinephrine (NEPI) to activate the cyclic adenosine 
monophosphate (cAMP) response element-binding protein (CREB); CREB induces the 
transcription of genes encoding for a variety of cytokines. Changes in gene expression 
result in a shift of immune response from T-helper lymphocyte type 1 cells (Th1) to T-
helper lymphocyte type 2 cells (Th2), which impairs the immune responses against 
tumor cells (Glaser & Glaser, 2005).  
In sum, psychological support for cancer patients is of paramount importance 
because when their psychological needs go unanswered it affects their general well 
being and, may impact the progress of the disease. The patients psychological 
condition also interferes with the physical treatment of the disease since, if left 
unattended, psychopathology as well as stress tend to influence the patients will to 
adhere to the treatment (Charmaz, 2000).  
 
4. Psychological Counseling in Cancer Patients  
A psychological intervention must be a part of any good-quality health care by 
managing the psychological, social and behavioral aspects of the patients life, thusly 
promoting better health and quality of life ( Kroenke et al., 2006). This is especially true 
for cancer patients because the impacts the disease has on their lives surpasses, as 
we have established, the physical aspect. Quality of life (QoL) can be defined as the 
state of complete physical, psychological, and social well-being (WHO, 1947) but it is 
also the perception of life, objectives, values, standards, and interests in the framework 
of culture (Dehkordi, Heydarnejad, & Fatehi, 2009). This means that QoL may be seen 
as a useful outcome measure regarding the effectiveness of psychological 
interventions.  
An oncological patient's counseling may vary from patient-education sessions 
(in group or individually), to solo counseling sessions, group counseling sessions, or 
family counseling sessions. All of which are always supported by information from other 
professionals in an interdisciplinary approach to health care. Whichever the approach 
to each patients situation, psychological interventions adjacent to oncological treatment 
aim for the patients to achieve psychological stability by removing or at least reducing 
the issues witch ail them (Gergurek et al., 2010). Patient-education sessions tend to 
focus on offering the patients (and sometimes their families) a better understanding of 
their illness as well as an empowerment of the patients own resources to deal with the 
psychosocial effects it may have (Andersen, 1992). Solo counseling sessions are 
20 
 
between the patient and a single therapist and can have multiple approaches to the 
patients problems, which vary depending on the therapists model of intervention 
(psychodynamic, cognitive-behavioral, systemic, humanist) and the specific 
intervention technique (in idem). Group counseling is an intervention where a group of 
patients with similar issues meet simultaneously with one or more therapists to discuss 
their issues with each other and with the therapist (in idem). Family counseling may 
include all family members or just two and usually focuses on the relationships of the 
patients and how the illness of one can be affecting the familial system (in idem). 
There have been conducted well over three-hundred studies of psychological 
interventions with cancer patients over the past sixty years (Newell, Sanson-Fisher, & 
Savolaine, 2002). Analysis of these various trials lead to the general consensus that 
different forms of psychological intervention, that teach relaxation and stress 
management techniques, facilitate the ventilation of the patient's feelings and anxiety 
improving their general quality of life (Antoni et al, 2006; Coyne, Stefanek, & Palmer, 
2007; Spiegel, 2002). These types of psychological intervention, however, are not the 
only ones to be associated with significant small-to-medium effects on the relief of 
emotional distress and increase of QoL (Faller et al., 2013). A meta-analysis of 198 
studies with 218 treatment-control comparisons concluded that significant small-to-
medium effects on the relief of emotional distress and increase of QoL were present in 
all individual and group psychotherapy and psycho-education interventions, with 
relaxation training presenting a higher short-term effect (in idem). Furthermore, a 
different meta-analysis of 20 studies conducted not only with the cancer patients but 
also their partners, showed that the inclusion of the partner in the intervention may 
have a small although beneficial effect in regards to the QoL of the patients and their 
partners (Badr & Krebs, 2013).  
Regarding the effectiveness of psychological interventions' influence on cancer 
progression and survival the results aren't very consensual since there exist various 
studies with different results and conclusions (Coyne, Stefanek, & Palmer, 2007; 
Kaufman, 2009; Newell, Sanson-Fisher, & Savolaine, 2002; Spiegel, 2002; Stefanek, 
Palmer, & Thombs, 2009). One study with patients with breast cancer on stage 2 to 3 
of the disease in the weeks post mastectomy randomly assigned patients either to 
standard care or 4 months of weekly and 8 months of monthly sessions of cognitive 
behavioral intervention (e.g. relaxation). Results showed that patients that underwent 
intervention presented a significant reduction in overall mortality rates and a reduced 
risk of breast cancer recurrence at a median of 11 years follow-up (Andersen et al, 
2008). Other recently completed investigations demonstrate that with cognitive 
behavioral interventions, combining relaxation-based techniques with cognitive 
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behavioral strategies it is possible to alter negative thinking and to build interpersonal 
coping skills. Furthermore psychological distress decreases while using relaxation as a 
coping strategy to manage stress and deal with distressful situations (Andersen, 
Shelby, & Golden-Kreutz, 2007; Phillips et al, 2008; Witek-Janusek et al, 2008). 
The patients point of view can be an essential part to a more effective 
counseling or therapeutic intervention. Thusly the ascertainment of the priority areas 
deemed distressful by the patient may be a useful information when it comes to 
planning the therapeutic intervention. 
 
5. Objectives and study rational 
This study intends to shed some light on the main areas that patients indicate 
as priorities for counseling. Using an idiographic measure we aim to better assess 
patients' issues and types of issues as a means to facilitate the therapists capacity to 
help and improve oncological counseling (Sollner et al., 2001). In 1988 Slevin and 
colleagues acknowledged that outcome measures focused on patient's concerns were 
of extreme importance to facilitate a more appropriate form of health care, and in all the 
years past that as only become more of a reality (Slevin et al., 1988). Thusly the more 
involved in their care process the patients are, the likelier the process is to succeed 
(Firzpatrick et al., 1998). However even if oncological patients are, as we've seen, 
subject to highly distressful situations they may not exhibit high levels of emotional 
distress and with strong social support and a high coping capacity they may not feel 
need for psychological counseling (Sollner et al., 2001). This is a vital information when 
because the patients level of emotional distress as well as their perception of that 
distress will determine their willingness to accept or adhere to the proposed counseling, 
just as their  do too (Clover, Mitchell, Britton, & Carter 2014). Four of the main 
idiographic instruments are the Psychological Outcome Profiles (Asworth et al., 2014), 
the Goal Attainment Scaling (Kiresuk & Sherman, 1968), the Target Complaints (Battle 
et al., 1966), and the Simplified Personal Questionnaire (Elliott, Mack & Shapiro, 1999), 
all these instruments share with the common goal of assessing the impact of the 
interventions from the point-of-view of the patient for the betterment of the therapeutic 
process (Sales & Alves, 2014). The idiographic measure was chosen over a more 
common interviewing process for the main reason that simple interviews would be to 
open to achieve our goal whereas an interview to construct an idiographic or 
personalized outcome measure provides a previous framework and facilitates both the 
analysis and its comparison to other studies. 
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With this in mind, the study is meant to appraise what are the most important 
problems cancer patients feel the disease causes and how they prioritize them, so that 
a base line of psychological counseling for cancer patients could be achieved. To do 
so, the idiographic measure chosen was the Personal Questionnaire, because it is a 
well crafted instrument which as shown its dependability on various previous studies 
(Sales, Alves, Evans & Elliott, 2014). In addition to the appraisal of problems and 
priorities the level of emotional distress of the patients will also be scrutinized in order 
to assess their need for psychological counseling. The levels of emotional distress will 
also be related to the clinical (e.g. type and stage of cancer)and socio-demographic 
(e.g. age and gender) characteristics of the patients, in order to identify eventual 
profiles of patients with different needs in psychological counseling. 
Summarizing, our study intends to fulfill three main goals: to assess the general 
emotional distress of the cancer patients; to identify patients problems and priorities for 
counseling; and to explore the relationship between the patient's emotional distress 

















The sample was comprised of 51 cancer patients, ages 21 to 80, being the 
gender distribution fairly equal with the women only slightly more represented (58%). 
Over 80% of the patients were married and most (36.7%) had two children. The 
majority of patients (48%) only had the basic literary abilities with only two of them (4%) 
having a Master's Degree or a Doctorate. In general the patients' sense of 
socioeconomic difficulties was low with only 10% considering maximum sense of 
difficulties and nearly 40% viewing them as minimal. Regarding clinical characteristics, 
most patients (37.3%) were in the treatment phase and had a digestive (45.1%) related 





Table 1: Patients' socio-demographic and clinical characteristics (n= 51). 
Characteristics Mean (SD) 
Age 58,35 (13,44) 
 Frequency (%) 
Gender  
Male 21 (42) 
Female 29 (58) 
Literary abilities  
4th grade 24 (48) 
6th grade 8 (16) 
9th grade 4 (8) 
12th grade 9 (18) 
Bachelor's Degree 3 (6) 
Master's Degree / Doctorate 2 (4) 
Martial State  
Single 5 (10,2) 
Married 40 (81,6) 
Widowed 2 (4,2) 
Living Together 1 (2) 
Divorced 1 (2) 
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Number of Offspring  
0 6 (12,2) 
1 12 (24,5) 
2 18 (36,7) 
3 9 (18,4) 
4 2 (4,2) 
8 1 (2) 
9 1 (2) 
Sense of Socioeconomic 
Difficulties 
 
Minimal 19 (38,8) 
2 7 (14,3) 
3 5 (30,6) 
4 3 (6,1) 
Maximal 5 (10,2) 
Phase of the Disease  
Diagnosis 3 (6.1) 
Treatment 19 (38.8) 
Advanced Disease 13 (26.5) 
Recurrence 3 (6.1) 
Survival 11 (22.5) 
Diagnosis Group  
Digestive 23 (45.1) 
Skin, Soft Tissue and Bone 11 (21.6) 
Urology and Gynecology 5 (9.8) 
Lung 5 (9.8) 





2.1. Socio-demographic and Clinical Questionnaire  
The socio-demographic questionnaire was created by the researchers to 
assess socio-demographic variables (age, gender, education, marital status, no 
children, socioeconomic status) and clinical variables (diagnosis, stage of disease, etc.) 
(Annex 4). 
2.2. 10-item Clinical Outcomes in Routine Evaluation questionnaire 
(CORE-10) 
The CORE-10 (Evans et al., 2000; Sales, Moleiro, Evans & Alves, 2012) is a 
generic measure used to review alterations of the psychological distress. It is 
shortened version of the CORE-OM, integrating only 10 of 34 total items, consisting 
therefore in a brief measure of screening and clinical review. The final results are 
calculated by adding the individual item scores and dividing by the total number of 
questions answered to attain a mean score ranging from 0 to 4. (Annex 1) 
2.3. Distress Thermometer (DT) 
The Distress Thermometer (Decat, Laros & Araujo 2009; Patrick-Miller, 
Broccoli, Much & Levine, 2004) is a questionnaire presented as a scale which calls for 
patients to assign a level to their emotional distress in the past week, from 0 (no 
distress) to 10 (extreme distress) with a cut-off at 4. This questionnaire is mainly used 
as a screening instrument (Annex 3).  
2.4. Simplified Personal Questionnaire (PQ) 
The Simplified Personal Questionnaire (Elliott, Mack, & Shapiro, 1999; Sales et 
al., 2007) is an individualized change measure consisting of approximately 10 
problems that a patient would like to work on in therapy. The PQ is thus constructed in 
a semi-structured interview with the duration of 45 minutes. The interview is meant to 
facilitate the patients description of their issues, which are then written on individual 
notes to be subsequently organized onto a standard form. The patients are then given 
the instruction to score each issue, on a scale of 1 (not at all) to 7 (maximum possible), 
according to the discomfort it has caused them in the past week. Each issue has an 
individual score but the mean score of all issues is also taken into account regarding 
the patients' emotional distress, for which the cut-off is a mean score of 3.25 (Elliott et 
al.,2016) (Annex 2). 
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2.5. Therapist's Adherence to PQ Protocol Questionnaire 
The Therapist's Adherence to Protocol Questionnaire is an instrument created 
by the researchers to assess the level of adherence to the PQ protocol by the therapist 
in each PQ application, for each of the steps as well as for the general adherence, 
ranging from 0(null adhesion) to 5(full adhesion) (Annex 5).  
The Simplified Personal Questionnaire Protocol is composed of six stages, 
starting with item generation where the items generated for the PQ should be the most 
important in the client’s view. However, an attempt should be made to include at least 
one problem regarding symptoms, mood, specific activities (e.g. work), relationships, 
and self-esteem. This means that if the client does not list a problem in a particular 
area, the interviewer should ask the client if there are any difficulties in that area that 
s/he wants to work on in therapy. The second stage is item clarification in which the 
interviewer helps the client to clarify his/her items and, if necessary, to rephrase the 
goals into problems. The interviewer begins by writing each problem onto a separate 
index card, revising it in the process. Refining PQ items requires discussion with the 
client to make sure that the PQ reflects his/her chief concerns. PQ items should be 
present as problems or difficulties, and should be worded “I feel,” “I am,” “I can’t,” “My 
thinking,”. After writing down the items, the interviewer asks the client if anything has 
been left out, adding further items as needed, until the client feels that the list is 
complete. The interviewer then reviews the items with the client, asking the client to 
revise or confirm them. If the client has generated more than 10 items, the interviewer 
asks the client to delete or combine repetitive items. If there are still more than 10 
items, the interviewer asks the client is s/he wants to drop any. The interview should 
not force the client to generate exactly 10 items; but try to obtain 8-12 items where 
possible. The next stage is item priority where  the interviewer asks the client to sort 
the index cards into order, with the most important concern first, writing the rank order 
of the item on the card. In the item scoring stage the interviewer gives the client a blank 
PQ form and the rank-ordered index cards, and asks the client to use the blank form to 
rate how much each problem has bothered him/her during the past week. The item 
duration stage is the fifth stage where using the Personal Questionnaire Duration Form 
the interviewer can find out how long each problem has bothered the client at roughly 
the same level or higher as it does now. The sixth and final stage is the item fill-in in 
which the interviewer types or writes the PQ items onto a blank PQ form, making at 
least 10 copies for future use. In doing so, it is a good idea to leave 2 spaces blank for 





3.1. Data collection 
The data was collected at Porto's Portuguese Institute of Oncology (IPO) by two 
psychologists on the first consultation with patients referred to the psychooncology 
department. The patients were selected by the psychologists from their daily 
consultation (consecutive sampling) following an exclusion criteria of underage 
patients, patients whose consultation was given in the inpatient ward and also patients 
whose first consultation was given by an intern. Patients who demonstrated severe 
emotional deregulation, severe cognitive limitations and severe physical limitations or 
discomfort were also excluded. This meant that from an original 83 patient 
consultations 39,8% were excluded from the study, resulting in a total of 51 patient 
considered (see Fig. 2). The data collection followed each instruments protocol and at 
the end of each session, the therapists would respond to the Adherence to PQ Protocol 
Questionnaire so that the adherence to the PQ protocol could also be considered data 
in and of itself. This study was subjected to and approved by the ethics committee of 
Porto's IPO. The data for the study was obtained over the span of four months, 
between December 2014 and March 2015. All patients who arrived at the consultations 
were asked, at the beginning of the session, if they would sign a disclosure agreement 

















Assessed for eligibility (n= 83) 
Excluded (n=33) 
 Not meeting inclusion criteria 
Eligible for study (n=51) 
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3.2. Data analysis  
To analyze the data for this study we began by assessing the quality through 
two procedures. First the PQ items' quality was assessed then the therapists 
adherence to the PQ protocol was also scrutinized. The second step of the data 
analysis consisted on the examination of patients emotional distress, as well as its 
relationship to personal and clinical variables (e.g. age, diagnosis). Finally the PQ data 
was thematically analyzed. 
 
3.2.1. Quality of PQ items 
For the analysis of the quality of the PQ items we used the item Rating 
System proposed by Elliott (2012), which classifies the quality of each free-text item 
according to the following criteria:1. Well-formed item: Specific, personal difficulty that 
is reasonably a focus for psychotherapy; 2. Items concerning Vague personal 
difficulties (e.g., relationships); 3. Items formulated as Goals instead of problems (e.g., 
get along better with people); 4. Items concerning General societal problems (e.g., 
general economic situation); 5. Other item quality issues (e.g. if the free text was in the 
patient's own words or if it was described by the therapist), meaning that only the first 
classification indicates high quality the rest describe various quality issues. Two 
independent judges classified each free text answer into the category that fits the item 
best with the discrepancies being discussed in order to reach a consensus. 
 
3.2.2. Therapist adherence to PQ protocol 
A descriptive analysis of the Therapist's Adherence to Protocol 
Questionnaire was carried out. 
 
3.2.3. Emotional distress of oncological patients 
For the analysis of the emotional distress of the patients we used a 
quantitative analysis of the CORE-10, the Distress Thermometer, and the PQ (mean 
scoring, duration). 
The relation between emotional distress and, clinical and socio-
demographic variables was determined as well through t-student and ANOVA 




3.2.4. Thematic analysis of the PQ items & Describing patients 
problems and priorities 
This analysis was based on the replication of the strategy used by 
Ashworth (Sales et al., 2016) on the qualitative analysis of PSYCHLOPS (Ashworth et 
al., 2004) - another well-studied individualized outcome measure - items. To begin with 
the free text responses were listed. Further analysis grouped responses into 
subthemes. Subthemes were derived by allocating responses into the simplest 
inclusive thematic categories if a response did not clearly fit into an existing subtheme 
then a new subtheme was created. Two independent judges classified each free text 
answer into the category that fits the item best with the discrepancies being discussed 
in order to reach a consensus. The subthemes were then organized in six broader 
categories following Elliott's PQ Content Categories (Robert, Lloyd & Susan, 2015) and 
an extra one for those which didn't fit any of the six: Interpersonal difficulties; 
Unresolved traumatic events; Self-related issues; Life functioning/skills/adjustment 
issues; Depression; Stress/anxiety; and Other problems. The analysis of this data was 
made in the light of both the number of items generated and the number of patients, 

















1. Quality of PQ items and Adherence to PQ protocol 
The quality of the PQ items was globally high, with 74% (n=144) well formed 
items. There were however some quality issues, chief among them was the 
existence of items describing vague personal difficulties (22%, n=43) (see Table 2). 
 
Table 2: Item quality classification (n=195) 
Item quality categories n (%) 
Well-formed 144 (73.85) 
Vague personal difficulties 43 (22.05) 
Goal 1 (0.51) 
General societal problems 4 (2.05) 
Other 3 (1.54) 
 
Even though the items were globally well formed, the therapists had difficulties 
following the PQ protocol to the letter with the average general adherence situated 
in the middle of the adherence scale (see table 3). The most difficult protocol 
components to follow were Item Priority (2.04 out of 5) and Item Clarification (2.64 
out of 5) being Item Scoring (4.18 out of 5) and Item Fill-In (4.11 out of 5) the ones 
where the protocol was more strictly followed.  
 
 




Item Generation 3.33 (1.00) 
Item Clarification 2.64 (1.11) 
Item Priority 2.04 (1.52) 
Item Scoring 4.18 (1.19)  
Item Duration 3.93 (1.42) 
Item Fill-In 4.11 (0.65) 





2. Emotional state of oncological patients 
The patients emotional state was not considered disturbing in two of the 
emotional state scales. The distress thermometer presented a slight elevation (5.94) 
from medium distress (cut-off is 4) and the CORE-10 results were (1.41) atop the 
cut-off point (10 for the CORE-OM which means 1 for the CORE-10). In contrast, the 
PQ average score results were situated on the dysfunctional range (5.13, above the 
cut-off point of 3.25) revealing a big discomfort felt by the patients regarding the 
problems described, as can be seen in Table 4.  
 
Table 4: Patients' emotional state scoring  
Emotional State Scales Mean (SD) 
CORE-10 1.41 (0.72) 
Distress Thermometer 5.94 (2.59) 
PQ Average Score 5.13 (1.16) 
 
Regarding the PQ specifically, the high discomfort gains even more relevance 
when we relate each patients average score to the cut-off (3.25) and conclude that 
only 3 patients were bellow it, one was on it and only three more were slightly above 
it (below 4). 
 
3. Problems and priorities of oncological patients 
The patients' problems and priorities were consistently distributed between the 
six broad categories achieved. The majority of the problems were related to life 
functioning issues (20.41%, N=40) and anxiety (19.39%, N=38). The rest were 
evenly divided between depression (16.33%, N=32), interpersonal difficulties 
(14.29%, N=28), other (14.80%, N=29), and self related issues (11.22%, N=22), 
while only 3.57% (N=7) were due to unresolved traumatic events. These 
percentages concern the PQ items formed.  
Regarding the number of patients that present each type of issue, most (80%) 
presented life functioning issues, the majority of which were linked to adapting to the 
restrictions caused by the disease, like "I feel limited by my health, I can't go out as I 
would like". These were followed by patients with depression issues (66.66%) like 
"I've lost the taste to do most things", and only 15.55% had unresolved traumatic 
events issues for example "Reliving negative experiences". Anxiety issues were 
presented by 57.77% of the patients, most of them related to some kind of fear such 
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as "Fear that the treatment is not being effective", while 48.88% of the patients had 
interpersonal difficulties issues, mainly with family, such as "The relationship with 
the wife has changed a lot" and another 48.88% had self related issues mostly 
related to self image like "Felling bad about how I look". Seeing as the broad 
category "other" presented one of the highest percentages, it is important to 
highlight that 53.33% of the patients had these types of issues. Half of these 
patients presented family concerns such as "Concern for the health of the children" 
while a quarter of them presented recurring negative thoughts (Table 5). 
 
Table 5: Patients' problems and priorities by item (N=195) & by patient 
(n=45) 
 






































Being a Smoker (1) 
Frustration (1) 
Financial difficulties (3) 
Pain (2) 
Making decisions for the future (1) 
Sexual difficulties (3) 
Adapting to the restrictions caused by the disease 
(21) 
 - unable to help grandson 
 - dietary changes 
 -  not having strength 
 - being taken care of / dependent on others 
 - lack of free time 
 - management of household chores 
 - not working 
 - general 
Disease Effects (3) 
 - losing your voice 
 - using ostomy bag 
 










Panic Attacks (1) 
Anxiety regarding treatment (4) 
Fear (20) 
 - surgical intervention 
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 -  treatment efficacy Anxiety 38 
(19.39) 
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 - relapse 
 - to die 
 - disease progression 
 - suffering 
 - side effects of treatment 
 - general 
 
















Sleeping problems (9) 
Sadness for reaching the end of life (1) 
Weariness (3 ) 
World View (2) 
Suicidal Ideation (1) 
Sadness - general (2) 
Despair (2) 
Loneliness (4) 
Lack of energy (2) 
De-motivation (1) 
Forebodings (1) 













Uncertainty towards the future (3) 
Uncertainty regarding life expectancy (1) 
Difficulties in identifying the problems (1) 
Body tension (1) 
Family concerns (12) 
 - General concern 
 - general concern for the children  
 - concern for the spouse 
 - concern with leaving others 
 - concern for the health of the children 


























Family Relationships (10) 
 - be a burden to the children 
 - change in the relationship with the 
spouse 
 - impatience 
 - convivial difficulties 
 - communication difficulties 
 - discuss the disease 
 - difficulty in relationships 
 - lack of support from the children 
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 - general 
Interpersonal relationship (11) 
 - Irritability / Aggressiveness 
 - avoidance / isolation 
 - negative view of others 
 - general 












Sense of Futility (3) 
Self image / Self esteem (8) 
Feeling of injustice (7) 
Vulnerability (1) 
Powerlessness (1) 
Lack of Concentration (1) 








07 Inability to Overcome the Disease (1) 
Reliving negative experiences (1) 
Confrontation with people in similar situations (1) 
Disease Acceptance (2) 





4. Patients' emotional distress related to personal and disease variables 
The correlation between the patients age and the distress scales indicated that 
it was only significant regarding the CORE-10 (r=-0.366, p= 0.009). The results 
indicated that there was a moderate negative correlation between the patients’ age and 
the CORE-10, which means that younger people feel more distressed (Table 6). 
Women presented a slightly higher degree of emotional distress on all scales 
(Distress Thermometer M=6.9, SE=0.52; C M=1.54, SE=0.16, PQ M=5.32, SE=0.23) 
than men (DT M=5.07, SE=0.48; C M=1.27, SE=0.13, PQ M=4.93, SE=0.27). 
However, this difference was only statistically significant for the Distress Thermometer, 




Table 6: Age related to psychological distress 
Subject's age related to: Pearson Correlation Sig. (2-tailed) N 
Distress Thermometer -0.236 0.102 49 
Core10Total -0.366 0.009 50 












 Male  Female    
 M SD n  M SD n  t df 
Distress 
Thermometer 
5.0741 2.47955 27  6.9048 2.38547 21 0.013 -1.83069 -2.580 46 
Core 10 Total 1.2682 0.68024 29  1.5422 0.71187 20 0.180 -0.27402 -1.360 47 










Moreover, having undergone, or not, a previous treatment, (either 
chemotherapy, radiotherapy or surgery) did not significantly associate to the levels of 
emotional distress shown by the patients on the CORE-10 and the Distress 
Thermometer. In contrast, patients who have undergone chemotherapy in the past 
indicated problems with a significantly lower intensity level in PQ than patients who 
have never undergone chemotherapy (Table 8). 
 
Table 8: Previous treatments related to psychological distress 







 No  Yes    
 M SD n  M SD n  t df 
Distress 
Thermometer 
6.4800 2.72519 25  5.5652 2.23253 23 0.212 0.91478 1.266 46 
Core 10 Total 1.3169 0.66284 25  1.5352 0.76085 24 0.289 -0.21830 -1.072 47 
PQ mean score 5.5760 1.10126 22  4.6779 1.06029 22 0.009 0.89812 2.756 42 







 No  Yes    
 M SD n  M SD n  t df 
Distress 
Thermometer 
6.0000 2.49878 42  6.3333 2.87518 6 0.765 -0.33333 -0.300 46 
Core 10 Total 1.4132 0.71950 43  1.5000 0.72938 6 0.783 -0.08682 -0.276 47 
PQ mean score 5.0665 1.12629 37  5.4464 1.38040 7 0.434 -0.37988 -0.790 42 







 No  Yes    
 M SD n  M SD n  t df 
Distress 
Thermometer 
5.8235 2.21459 17  6.1613 2.69687 31 0.661 -0.33776 -0.441 46 
Core 10 Total 1.4542 0.64842 17  1.4076 0.75544 32 0.830 0.04661 0.215 47 
PQ mean score 4.8569 1.21613 16  5.2813 1.12104 28 0.248 -0.42435 -1.171 42 







 No  Yes    
 M SD n  M SD n  t df 
Distress 
Thermometer 
5.9767 2.46391 43  6.6000 3.20936 5 0.606 -0.62326 -0.520 46 
Core 10 Total 1.4578 0.71065 44  1.1244 0.74624 5 0.327 0.33338 0.990 47 







Referring to the influence of current treatments on the patient's emotional 
distress, it did not differ significantly between the three types of treatment or the non 
existence of treatment (Table 9). This means that for the patients the type of treatment, 
or the existence of any, and the moment for it have no relevant association to their 
emotional distress. 
 
Table 9: Current treatments related to psychological distress 







 No  Yes    
 M SD n  M SD n  t df 
Distress 
Thermometer 
6.0000 2.25320 27  6.0952 2.87932 21 0.898 -0.09524 -0.129 46 
Core 10 Total 1.4691 0.74708 27  1.3682 0.68340 22 0.627 0.10095 0.489 47 
PQ mean score 5.2949 1.08388 25  4.9060 1.24994 19 0.276 0.38887 1.103 42 







 No  Yes    
 M SD n  M SD n  t df 
Distress 
Thermometer 
6.0476 2.35768 42  6.0000 3.74166 6 0.966 0.04762 0.043 46 
Core 10 Total 1.4527 0.70171 43  1.2167 0.83287 6 0.454 0.23605 0.756 47 
PQ mean score 5.1046 1.14183 38  5.2685 1.38351 6 0.752 -0.16388 -0.318 42 







 No  Yes    
 M SD N  M SD N  t df 
Distress 
Thermometer 
5.9778 2.52703 45  7.0000 2.64575 3 0.502 -1.02222 -0.677 46 
Core 10 Total 1.4036 0.71569 46  1.7333 0.73711 3 0.444 -0.32971 -0.772 47 
PQ mean score 5.0916 1.18625 41  5.6111 0.67358 3 0.461 -0.51955 -0.744 42 







 No  Yes    
 M SD N  M SD n  t df 
Distress 
Thermometer 
6.5000 2.72845 28  5.4000 2.08756 20 0.137 1.10000 1.513 46 
Core 10 Total 1.4034 0.71388 29  1.4533 0.73066 20 0.813 -0.04989 -0.238 47 








Regarding the influence phase of treatment may have had on patient's 
emotional distress the results show that the average distress did not differ significantly 
between the five phases for each scale (Table 10). Which means that the different 
phases of treatment in which the patients may find themselves had very little relation to 
the change of their emotional distress. 
 








Diagnosis 5.0000 (3.00000) 1.73205 -2.4524 12.4524 
Treatment 6.0556 (2.95997) 0.69767 4.5836 7.5275 
Advanced Disease 6.5833 (2.64432) 0.76335 4.9032 8.2635 
Recurrence 4.6667 (1.52753) 0.88192 0.8721 8.4612 
Survival 5.5455 (1.86353) 0.56187 4.2935 6.7974 
Core10Total Diagnosis 0.9074 (0.68892) 0.39775 -0.8040 2.6188 
Treatment 1.3813 (0.73358) 0.16829 1.0277 1.7349 
Advanced Disease 1.2796 (0.73727) 0.21283 0.8112 1.7481 
Recurrence 1.2667 (0.32146) 0.18559 0.4681 2.0652 
Survival 1.6818 (0.74272) 0.22394 1.1829 2.1808 
PQ mean 
score 
Diagnosis 4.3750 (1.94454) 1.37500 -13.0960 21.8460 
Treatment 4.9403 (0.96232) 0.23340 4.4455 5.4350 
Advanced Disease 5.3601 (1.43647) 0.43311 4.3951 6.3251 
Recurrence 5.9167 (0.58926) 0.41667 0.6224 11.2109 
Survival 5.0458 (1.10299) 0.34880 4.2568 5.8349 
 
Sum of 
Squares df Mean Square F 
Distress 
Thermometer  
Between Groups 14.405 4 3.601 0.534 
Within Groups 283.255 42 6.744  
Total 297.660 46   
Core10Total Between Groups 1.828 4 0.457 0.880 
Within Groups 22.338 43 0.519  
Total 24.166 47   
PQ mean score Between Groups 3.591 4 0.898 0.657 
Within Groups 50.529 37 1.366  








As for diagnosis, the association to the patient's emotional distress did not differ 
significantly between the five cancer groups for each scale although on the PQ mean 
scores there was a slightly stronger relation (Table 11). 
 








Digestive 6.2273 (2.58073) 0.55021 5.0830 7.3715 
Skin, Soft Tissue, Bone 5.8182 (2.08893) 0.62984 4.4148 7.2215 
Urology and  Gynecology 5.8000 (3.76829) 1.68523 1.1211 10.4789 
Lung 5.2500 (4.11299) 2.05649 -1.2947 11.7947 
Others 5.7143 (2.13809) 0.80812 3.7369 7.6917 
Core10Total Digestive 1.4136 (0.67089) 0.14304 1.1162 1.7111 
Skin, Soft Tissue, Bone 1.4000 (0.62290) 0.18781 0.9815 1.8185 
Urology and  Gynecology 1.2000 (1.08858) 0.48683 -0.1516 2.5516 
Lung 0.9444 (0.70702) 0.31619 0.0666 1.8223 
Others 1.8714 (0.62106) 0.23474 1.2970 2.4458 
PQ mean 
score 
Digestive 4.9417 (1.02680) 0.22960 4.4612 5.4223 
Skin, Soft Tissue, Bone 5.4383 (1.14242) 0.38081 4.5601 6.3164 
Urology and  Gynecology 6.,3688 (0.67866) 0.33933 5.2889 7.4486 
Lung 4.4375 (1.83002) 0.91501 1.5255 7.3495 
Others 4.9405 (1.01461) 0.38349 4.0021 5.8788 
 
Sum of 
Squares df Mean Square F 
Distress 
Thermometer  
Between Groups 4.338 4 1.084 0.150 
Within Groups 318.479 44 7.238  
Total 322.816 48   
Core10Total Between Groups 2.975 4 0.699 1.405 
Within Groups 22.386 45 0.497  
Total 25.181 49   
PQ mean 
score 
Between Groups 9.872 4 2.468 2.002 
Within Groups 48.078 39 1.233  

















The main purpose of this study was to ascertain what our sample of cancer 
patients views as the most important issues ailing them. We found that the third most 
important type of issue for the patients was depression, manly anhedonia. These 
results were unsurprising as depression tends to always be present in cancer patients 
in some manner, even when the DSM criteria for major and minor depression are not 
met many depressive symptoms tend to exist in cancer patients, such as sleeping 
alterations, anhedonia, and eating alterations (Pasquini & Biondi, 2007). 
The second most important issues were the anxiety issues, mostly related to 
fear of the way the disease will develop. This was expected since a fear of disease 
progression is a reasonable response to a cancer diagnosis and its treatment options 
(Herschbach & Dinkel, 2014), and according to a 2013 study 56% of patients 
diagnosed with cancer for the first time present high fear regarding the progression of 
the disease (Savard & Ivers, 2013). 
Another interesting result was the fact that many patients pointed out the 
difficulty in dealing with their concern for others, namely their family members, by not 
wanting to burden them. This is a common result when inquiring cancer patients since 
the disease can affect the patient autonomy and informal caregivers become a crucial 
part of their lives (Lim, Kim, Lee, 2013). 
Finally we found that the most prominent types of problems for our sample of 
cancer patients to overcome in therapy were regarding the adaptation to the 
psychosocial implications of the disease and the limitations it can cause were. A 2011 
meta-analysis of interview-based studies supports our findings as it showed that major 
depression and anxiety are less common in cancer patients than believed while 
adjustment disorder gains more weight. In 70 different studies with 10071 patients in 
oncological and haematological settings the prevalence of major and minor depression 
as defined by the Diagnostic and Statistical Manual of Mental Disorders (DSM) was 
14.9% and 19.2% respectively and for anxiety disorders it was 10.3% while adjustment 
disorder alone presented a prevalence of 19.4% (Mitchell, et al., 2011).  
The results obtained by this study were coherent with what we found in the 
literature (Akechi et al., 2001; Charmaz, 2000; Grassi et al., 2004; Gregurek et al., 
2010; Herschbach & Dinkel, 2014; Jacobsen et al., 2000; Kissane et al., 2004; 
Kornblith, 1998; Lim, Kim, Lee, 2013; Mitchell et al., 2011; Miovic & Block, 2007; 
Mystakidou et al., 2005; Pasquini & Biondi, 2007; Stanton et al., 2001; Savard & Ivers, 
2013) and seem to indicate that in initial psychological counseling with oncological 
patients therapists should focus on helping them overcome their perceived limitations 
or to better adjust to their real ones in the quotidian.  
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Interventions focusing on managing the medical aspects of the illness, the life 
roles and their changes brought on by the illness as well as managing the 
psychological consequences of the illness have made significant progress in facilitating 
the management of both physical and psychological symptoms related to cancer and 
its treatments (McCorkle et al., 2011). Which goes to show that this approach to 
psychological counseling with oncological patients seems to be effective by focusing on 
the types of issues referred by our sample of cancer patients. 
Regarding the influence personal and disease variables may have had on the 
patients emotional distress it should be highlighted that women tend to show higher 
levels of distress in all of the scales although the values are only significant for the 
Distress Thermometer. These results are consistent with other studies relating stress 
and gender, where although both genders report, on average, a similar level of stress 
women tend to report that their stress levels are on the rise more than men. As well as 
report higher physical and emotional symptoms of stress (Calvarese, 2015; Campbell & 
Svenson, 1992; Chaplin, Hong, Bergquist, & Sinha, 2008). 
The problems patients with a history of chemotherapy present in the PQ have a 
lower level of intensity than the problems presented by people who have never 
undergone the same treatment. These results may be linked to the fact that the people 
who have already undergone the treatment before have a clearer notion of what to 
expect from it (Anjos & Zago, 2005). This becomes evident when comparing the issues 
raised by each group, the categories don't differ significantly but the patients who have 
undergone chemotherapy present a higher number of life functioning issues like "Being 
still, not feeling useful", "Being unable to work", or "I feel limited by my health, I can't go 
out as much as I would like", while patients who have not present more anxiety issues, 
particularly fears regarding the treatment such as "Fear the treatment isn't going to 
work", "I feel anxious to start the treatment", and "Fear of the physical pain". That being 
said, it becomes apparent that it should be given a special attention to the fear patients 
have regarding the treatment's efficacy and the side effects it may have, for patients 
undergoing their first chemotherapy treatment. 
As to the level of emotional distress the disease has brought upon the patients, 
it was surprisingly not very elevated in the two principal scales used for its 
measurement - the Distress Thermometer and the CORE-10. The slight elevation on 
the distress results may be explained by the sample selection since the patients in a 
more critical state both physically and emotionally were excluded. A previous study at 
Porto's IPO showed similarly low results in regards to the Distress Thermometer where 
245 patients averaged an emotional distress level of 3.86 (Silva & Castro, 2009).  
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When it came to the PQ, the level of emotional distress was considerably 
higher, the difference found between the PQ results and the other two scales may be 
due to the latter being generic nomothetic anxiety and depression measures and the 
first an individualized measure which allows the patient to point out sources of 
psychological distress that are not foreseen in nomothetic measures. A previous study 
of 2015 supports this as it found that out of 107 patients 74% reported at least one 
problem in an individualized outcome measure, the Psychological Outcome Profiles 
(PSYCHLOPS), that was not covered by the nomothetic measure, the CORE-OM 
(Neves, 2015). For example, the fear patients have regarding the treatment's efficacy 
and the side effects it may have is not a complaint foreseen in the CORE-10 but was 
present in the PQ, as well as feelings of injustice or the problems regarding the patients 
adaptation to the restrictions caused by the disease.  
Even though the PQ seems to be a more sensitive measure to the patients 
problems, following its protocol in an hospital context with an oncological population 
seems to be challenging. The data referring to therapists adhesion to the PQ protocol 
should be taken into account since out of the protocol's six stages none were followed 
exactly and two of them were very arduous to uphold - item priority and item 
clarification. The main reasons for the difficulties in following the protocol exactly were 
the many tasks a first consultation entails and the limited time frame the therapists had 
to apply the PQ. Regarding the two specific stages with the least adherence, the main 
issue was the use of the index cards which the therapists felt was counterproductive 
and extra time consuming. For these reasons we do not recommend the future use of 
the Simplified Personal Questionnaire as an investigative instrument in this context, 
perhaps a shorter individualized self-report measure such as the PSYCHLOPS - the 
patient has the possibility to develop three items of greater relevance to their clinical 
status covering three domains, problems, functionality, and perceived well being 
(Ashworth et al.,2004)  - may be more useful and as far as we know a have not yet 
been used in this context.   
This study was not without limitations, the most glaring of which was the size of 
the sample that limited our capability of extrapolating our results to the general 
oncological population. The other limitation of our study was already addressed above 
and regards the adherence to the PQ protocol which was low and therefore may be 
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Annex 4: Socio-demographic and Clinical Questionnaire  
 
Sujeito: _____                                                                             Consulta:      1ª      2ª 
DADOS SOCIOBIOGRÁFICOS 
Idade: _____ (anos) 
Género:       M        F 
 
Escolaridade:      4º ano      6º ano      9º ano      12º ano 
                             Bacharelato/Licenciatura      Mestrado/Doutoramento 
 
Estado Civil:      Solteiro      Casado      Viúvo      União de facto      Divorciado 
 
Nº Filhos: _____ 
 
Estatuto Socioeconómico: 
 Até que ponto sente que tem dificuldades económicas? 







Fase da Doença: __________ 
 
História de Tratamento: 
 Tratamento Prévio:      Quimioterapia      Radioterapia      Cirurgia 
                                                   Nenhum   
 Tratamento Atual:      Quimioterapia      Radioterapia      Cirurgia 
                                                 Nenhum  
 
História Psicopatológica: 
 Diagnóstico Prévio:      _________________________________     Não 




Annex 5: Therapist's Adherence to Protocol Questionnaire 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
